Page last updated: 2024-08-23

ursodeoxycholic acid and Autosomal Dominant Cerebellar Ataxia, Type II

ursodeoxycholic acid has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kaemmerer, WF; Low, WC; Rodrigues, CM; Steer, CJ	1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Autosomal Dominant Cerebellar Ataxia, Type II

Article	Year
Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype. Neuroscience, 2001, Volume: 103, Issue:3 Topics: Animals; Ataxin-1; Ataxins; Bile Acids and Salts; Cell Count; Cell Survival; Cerebellum; Creatine; Dietary Supplements; Gait; Humans; Injections; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Phenotype; Phosphocreatine; Purkinje Cells; Reference Values; Spinocerebellar Ataxias; Taurine; Ursodeoxycholic Acid	2001

Article

Year

Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.

Neuroscience, 2001, Volume: 103, Issue:3

Topics: Animals; Ataxin-1; Ataxins; Bile Acids and Salts; Cell Count; Cell Survival; Cerebellum; Creatine; Dietary Supplements; Gait; Humans; Injections; Mice; Mice, Transgenic; Motor Activity; Nerve Tissue Proteins; Nuclear Proteins; Phenotype; Phosphocreatine; Purkinje Cells; Reference Values; Spinocerebellar Ataxias; Taurine; Ursodeoxycholic Acid

2001